Ghaedi, Forugh Etesami, Ifa Aryanian, Zeinab Kalantari, Yasamin Goodarzi, Azadeh Teymourpour, Amir Tavakolpour, Soheil Mahmoudi, HamidReza Daneshpazhooh, Maryam
Published in
International immunopharmacology
Pemphigus encompasses a rare heterogeneous group of autoimmune blistering diseases characterized by cutaneous and/or mucosal blistering. Multiple factors, such as some specific types of drugs, have been found to be involved in the induction of pemphigus. Here, we have designed a systematic review by searching PubMed/Medline and Embase databases to ...
Mohamed, Heba A Said, Riham S
Published in
International immunopharmacology
Radiation enteropathy is one the most common clinical issue for patients receiving radiotherapy for abdominal/pelvic tumors which severely affect the quality of life of cancer patients due to dysplastic lesions (ischemia, ulcer, or fibrosis) that aggravate the radiation damage. Herein, this study demonstrated the prophylactic role of coenzyme Q10 (...
Guo, Ran Wang, Wenxuan Yu, Lanzhi Zhu, Zhixiang Tu, Pengfei
Published in
International immunopharmacology
CD40 ligand (CD40L) and B-cell activating factor (BAFF) play important roles in the function of B cells. However, the difference of their regulatory effects remains obscure. In this study, we used anti-CD40 to imitate CD40L and investigated the different regulatory effects of CD40L and BAFF on the function of B cells. In the functional analyses, bo...
Deadame de Figueiredo Nicolete, Larissa Vladimiro Cunha, Celso Paulo Tavanez, João Tomazini Pinto, Mariana Strazza Rodrigues, Evandra Kashima, Simone Tadeu Covas, Dimas Miguel Villalobos-Salcedo, Juan Nicolete, Roberto
Published in
International immunopharmacology
The treatment for hepatitis Delta virus (HDV) still consists of Pegylated interferon (PEG-IFN) combined with inhibitors of Hepatitis B virus (HBV) replication. In some patients may be occur a virological response, which means a negative HDV RNA 6 months after stopping treatment. In this study it was conducted an in vitro approach with the aim to mi...
Zhang, Weikang Cao, Ding Wang, Menghao Wu, Yakun Gong, Jianping Li, Jingzheng Liu, Yiming
Published in
International immunopharmacology
Polarized kupffer cells (KCs) influence the immune response after liver transplantation. We report an undiscovered immune regulatory role of X-box binding protein 1 (XBP1) on immune function of kupffer cells (KCs). Acute rejection model using rats. We found that suppression of XBP1s in lipopolysaccharide (LPS) -activated KCs could increase the expr...
Sherif, Iman O Al-Shaalan, Nora H
Published in
International immunopharmacology
Lung injury is a serious condition encountered following hepatic ischemia/reperfusion (IR). This study aimed to explore whether a dipeptidyl peptidase-4 inhibitor agent vildagliptin (V) could alleviate the lung injury caused by hepatic IR in a rat model and if so elucidate its molecular protective mechanism. Three groups of rats were used. Sham gro...
Liang, Liang Zheng, Yage Xie, Yinping Xiao, Ling Wang, Gaohua
Published in
International immunopharmacology
Oridonin (Ori) has multiple biological properties, especially anti-inflammatory. However, its effects on chronic unpredictable mild stress (CUMS)-induced insulin resistance are still unclear. In this study, we explored the regulatory role of Ori in CUMS-triggered insulin resistance, and the underlying molecular mechanisms; Methods: SD rats were sub...
Hiramitsu, Takahisa Tomosugi, Toshihide Futamura, Kenta Okada, Manabu Nishihira, Morikuni Goto, Norihiko Ichimori, Toshihiro Narumi, Shunji Kobayashi, Takaaki Uchida, Kazuharu
...
Published in
International immunopharmacology
Chronic antibody-mediated rejection, caused by de novo donor-specific antibody (dnDSA) production, results in poor graft survival. To prevent dnDSA production, optimal blood levels of immunosuppressive drugs in living donor kidney transplant recipients were determined. A total of 772 recipients underwent living donor kidney transplantation between ...
Ghosh, Srijit Das, Srijita Mondal, Rupsa Abdullah, Salik Sultana, Shirin Singh, Sukhbir Sehgal, Aayush Behl, Tapan
Published in
International immunopharmacology
COVID-19 is considered the most critical health pandemic of 21st century. Due to extremely high transmission rate, people are more susceptible to viral infection. COVID-19 patients having chronic type-2 asthma prevails a major risk as it may aggravate the disease and morbidities. The present review mainly focuses on correlating the influence of COV...
Wu, Yongcan Xiao, Wei Pei, Caixia Wang, Mingjie Wang, Xiaomin Huang, Demei Wang, Fei Wang, Zhenxing
Published in
International immunopharmacology
Astragaloside IV (AS IV) is antioxidant and anti-inflammatory product, which is extracted from the Chinese herb Astragalus membranaceus. It is widely used in a variety of inflammatory diseases. The research was to explored the protective effects of AS IV against lung injury induced by particulate matter 2.5 (PM2.5) in vivo. Thirty-five male Sprague...